Jonathan Mark Hopper insider trades

Open-market stock purchases and sales by Jonathan Mark Hopper, Chief Medical Officer at Vericel Corp, from SEC Form 4 filings since Apr 12, 2016.

Recent trades

DateStockTradeValue
Jun 26, 2026VCEL Vericel CorpSold$225K
Jun 26, 2026VCEL Vericel CorpBought (not open market)—
Jun 2, 2026VCEL Vericel CorpSold$153K
Jun 2, 2026VCEL Vericel CorpBought (not open market)—
Apr 2, 2026VCEL Vericel CorpSold$122K
Apr 2, 2026VCEL Vericel CorpBought (not open market)—
Feb 24, 2026VCEL Vericel CorpSold (not open market)$50.9K
Feb 24, 2026VCEL Vericel CorpSold (not open market)$24.3K
Feb 24, 2026VCEL Vericel CorpBought (not open market)—
Feb 24, 2026VCEL Vericel CorpBought (not open market)—
Feb 24, 2026VCEL Vericel CorpBought (not open market)—
Feb 19, 2026VCEL Vericel CorpBought (not open market)—
Feb 19, 2026VCEL Vericel CorpBought (not open market)—
Feb 18, 2026VCEL Vericel CorpSold (not open market)$36.7K
Feb 18, 2026VCEL Vericel CorpBought (not open market)—
Feb 18, 2026VCEL Vericel CorpBought (not open market)—
Dec 2, 2025VCEL Vericel CorpSold$64.7K
Dec 2, 2025VCEL Vericel CorpBought (not open market)—

Companies traded

  • VCEL Vericel Corp: 23 sales, last Jun 26, 2026
  • OSIR Osiris Therapeutics, Inc: other filings, last Apr 12, 2016

Get free alerts when Jonathan Mark Hopper files a new trade →